Synthesis, immunosuppressive activity and structure-activity relationship study of a new series of 4-N-piperazinyl-thieno[2,3-d]pyrimidine analogues

Catholic University of Leuven, Rega Institute, Laboratory of Medicinal Chemistry, Minderbroedersstraat 10, 3000 Leuven, Belgium.
Bioorganic & medicinal chemistry letters (Impact Factor: 2.33). 02/2010; 20(3):844-7. DOI: 10.1016/j.bmcl.2009.12.098
Source: PubMed

ABSTRACT The synthesis of a new series of 4-N-piperazinyl-thieno[2,3-d]pyrimidines is described. The synthetic route allows introducing structural variety at positions 2, 4 and 6 of the scaffold. Evaluation of their immunosuppressive activity in a Mixed Lymphocyte Reaction (MLR) assay revealed that the most potent compound has an IC(50)-value of 66 nM and therefore deserves attention for further medicinal chemistry optimization.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The synthetic potency of readily accessible, ethyl 2-amino-4-methyl-5-(4-nitrophenoxy)thiophene-3-carboxylate (1) as a versatile precursor for the synthesis of novel polyfunctionally substituted thienopyrimidines is reported. The latter derivatives undergo further heterocyclisation to the related polycyclic fused systems via reactions with different reagents.
    Journal of Chemical Research 10/2010; 34(10). DOI:10.3184/030823410X12863009209478 · 0.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A series of novel cycloalkylthieno[2,3-d]pyrimidinone derivatives have been conveniently synthesized via three steps including G-3CR, heterocyclization, and alkylation reactions as a part of our ongoing search for new bioactive molecules. The newly synthesized compounds were evaluated for their potential tumor cell growth inhibitory activity by standard MTT assay. The preliminary results show that compound 6b exhibited better inhibitory activities against HepG2, MCF-7, and BCG-823 cell lines compared to the control.
    08/2013; 2013. DOI:10.1155/2013/692074
  • [Show abstract] [Hide abstract]
    ABSTRACT: An improved and convenient synthetic route for the synthesis of peramivir has been developed with a total 34% yield. The process was improved from previous methods in three key reaction steps including 1,3-dipolar cycloaddition, reductive ring cleavage of the isoxazoline, and incorporation of the peripheral guanidino group. First, an activated sodium hypochlorite (Cl% = 10%) was employed for the catalytic 1,3-dipolar cycloaddition, and 61–68% yields were obtained. Second, the NaBH4-NiCl2 was used as a new reducing reagent instead of the expensive catalyst PtO2. Most important, an innovative and environmentally friendly method of guanylation in the final step was developed using chloroformamidine hydrochloride as the amidino reagent, which avoided the use of the highlytoxic reagent of HgCl2 and made the process greener.Supplemental materials are available for this article. Go to the publisher's online edition of Synthetic Communications® to view the free supplemental file.
    Synthetic Communications 10/2013; 43(19). DOI:10.1080/00397911.2012.729279 · 0.98 Impact Factor